inpefa：highlights of prescribing information

highlights of prescribing information

INPEFAisaprescriptionmedicineusedtoreducetheriskofdeathduetoheartproblems(cardiovasculardeath),hospitalizationforheartfailure,andurgent ...。其他文章還包含有：「FDAApprovesInpefafortheTreatmentofHeartFailure」、「INPEFAcancauseserioussideeffects」、「InpefaOral:Uses,SideEffects,Interactions」、「Inpefa:Uses,Dosage」、「INPEFATM(sotagliflozin)tablets」、「NowApproved」、「Once」、「Sotagliflozi...

查看更多離開網站

Provide From Google

FDA Approves Inpefa for the Treatment of Heart Failure

https://www.empr.com

The Food and Administration (FDA) has approved Inpefa™ (sotagliflozin) to reduce the risk of cardiovascular (CV) death, hospitalization for ...

Provide From Google

INPEFA can cause serious side effects

https://dailymed.nlm.nih.gov

INPEFA is a prescription medicine used to reduce the risk of death due to heart problems (cardiovascular death), hospitalization for heart failure, and urgent ...

Provide From Google

Inpefa Oral: Uses, Side Effects, Interactions

https://www.webmd.com

Sotagliflozin is used by people with heart failure or by people with type 2 diabetes, kidney disease, and other heart disease risk factors to lower the risk ...

Provide From Google

Inpefa: Uses, Dosage

https://www.drugs.com

Inpefa is an oral, once-daily tablet that contains sotagliflozin which may be used to reduce the risk of cardiovascular death, ...

Provide From Google

INPEFATM (sotagliflozin) tablets

https://www.accessdata.fda.gov

INPEFA is not indicated for glycemic control. Type 2 diabetes mellitus and pancreatic disorders (e.g., history of pancreatitis or pancreatic surgery) are also ...

Provide From Google